Could a common mineral slow Parkinson's? new trial begins
NCT ID NCT06592014
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether low-dose lithium aspartate, a dietary supplement, can slow the progression of Parkinson's disease. It involves 35 people who have already completed a lithium trial, and they will take lithium for another 24 weeks. Researchers will use brain scans and blood tests to look for changes in key markers of the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
lithium aspartate (a dietary supplement form of lithium)
What this could lead to
If it works, this could point toward a way to slow Parkinson's disease progression using a low-cost, repurposed supplement.
What could go wrong
This is a small, early-phase open-label trial with no placebo group, so results may be due to chance or bias. Lithium can cause side effects like kidney or thyroid issues, even at low doses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UBMD Neurology
Williamsville, New York, 14221, United States